title: Reaction of cyclohexylamine with hypochlorite and enhancement of oxidation of plasma sulfhydryl groups by hypochlorite in vitro.
abstract: In this study we investigated the reaction of cyclamate and its major metabolite, cyclohexylamine (CyhNH2), with NaOCl. NaOCl at 100 microM was allowed to react with various concentrations of cyclamate and CyhNH2, and the reactivity was compared with those of reduced glutathione (GSH) and ascorbic acid. The results showed that CyhNH2 was less reactive with NaOCl than GSH but was slightly more reactive than ascorbic acid at concentrations below 50 microM. CyhNH2 at 75 and 100 microM did not further decrease NaOCl. Cyclamate was much less reactive than CyhNH2, with only 43% loss in NaOCl at 100 microM cyclamate. When human blood plasma was incubated with 0.75 microM NaOCl, inclusion of CyhNH2 enhanced oxidation of sulfhydryl groups in a concentration-dependent manner, with complete oxidation of SH groups at 7.5 mM CyhNH2. Cyclamate had no effect. This enhancement by CyhNH2 suggests the formation of reactive products from the reaction of CyhNH2 with NaOCl. Absorption spectra demonstrated that reaction of CyhNH2 with NaOCl at pH 7.4 produced N-monochloramine, as evidenced by the appearance of a new peak at 245 nm and by the disappearance of the 292-nm peak of NaOCl. Cyclamate, which contains a sulfamic acid instead of a primary amine, also reacted with NaOCl at pH 7.4, but the reaction was much less pronounced and the product was probably not monochloramine since the peak was at 270 nm rather than at 245 nm. Because cyclamate is an important sweetener in many countries for people with diabetes mellitus, the possibility exists that CyhNH2 may enhance oxidation of important proteins by HOCl/OCl-.
authors.affiliation: Department of Food Science, National Chung-Hsing University, Taichung, Taiwan, ROC.
authors.forename: M L
authors.initials: ML
authors.lastname: Hu
authors.forename: H H
authors.initials: HH
authors.lastname: Tsai
mesh_terms: D001205:Ascorbic Acid / Q000737:chemistry / Q000378:metabolism; D003494:Cyclamates / Q000737:chemistry / Q000378:metabolism; D003514:Cyclohexylamines / Q000737:chemistry* / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005978:Glutathione / Q000737:chemistry; D006801:Humans; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D016877:Oxidants / Q000494:pharmacology*; D010084:Oxidation-Reduction; D012973:Sodium Hypochlorite / Q000737:chemistry* / Q000494:pharmacology*; D013056:Spectrophotometry, Ultraviolet; D013438:Sulfhydryl Compounds / Q000097:blood* / Q000737:chemistry*
chemical_list: D003494:Cyclamates; D003514:Cyclohexylamines; D016877:Oxidants; D013438:Sulfhydryl Compounds; D012973:Sodium Hypochlorite; D005978:Glutathione; D001205:Ascorbic Acid